The impact acceleration model of diffuse traumatic brain injury (DTBI), commonly referred to as the “Marmarou” weight drop model is widely utilized to replicate DTBI, without focal lesion to characterize changes that closely parallel abnormalities characteristic of human DTBI cause by motor vehicle accidents or falls. In this chapter, we describe in detail procedures used to replicate DTBI of varying degrees of severity; the clinically relevant condition of posttraumatic hypoxia and hypotension; and experimental paradigms utilized for intraoperative multiparameter, physiological monitoring. We provide brief summaries of reproducible outcome evaluations characteristic of this model inclusive of (1) intraoperative physiological responses including mean arterial blood pressure (MABP), pH, pO2, and pCO2, and intra-cranial pressure (ICP); (2) gross and neurohistopathological outcomes; (3) functional studies that highlight somatomotor and cognitive behavioral changes; (4) in vitro outcome evaluations employing magnetic resonance imaging (MRI), 1H Magnetic resonance spectroscopy (1H MRS); and (5) high-performance liquid chromatography (HPLC) for the analysis of changes in cellular function, brain edema and cerebral metabolites including N-acetyl-aspartate (NAA) and adenosine tri-phosphate. Finally, we describe the complications associated with the use of this model, mainly technical in nature, easily overcome with repetitious practice and State limitations of this model, notably the use of multiparameter intraoperative monitoring techniques that can be costprohibi-tive due to the expense of the required equipment. We conclude by stating the major advantage of this model; it has been used extensively in the laboratory to evaluate the effect of pharmacological intervention to treat DTBI. Importantly, these treatments have recently reached Phase II & III clinical trial status.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marmarou A, Foda MA, Van Den Brink W, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats Par I: Pathophysiology and biomechan-ics. J Neurosurg 1994; 80: 291–300
Foda MA, Marmarou A. A new model of diffuse brain injury in rats Part II: Morphological characterization. J Neurosurg 1994; 80: 301–13.
Adams JH, Doyley D, Ford I, Gennarelli TA, Graham DI and McLellan DR: Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology 1989; 15: 49–59
Marshall LF, Gautille T, Klauber MR, Eisenberg HM, Jane J, Luessen TG, Marmarou A, Foulkes MA. The outcome of sever closed head injury. J Neurosurg 1991; 71: S28–S26.
Yamamoto M, Marmarou CR, Stiefel MF, Beaumont A, Marmarou A. Neuroprotective effect of hypothermia on neuronal injury in diffuse traumatic brain injury coupled with hypoxia and hypotension. J Neurotrauma 1999;16: 487–500.
Ito J, Marmarou A, Barzo P, Fatouros P, Corwin F. Characterization of edema by diffusion-weighted imaging in experimental traumatic brain injury. J Neurosurgery 1999; 84: 97–103
Marmarou CR, Walker SA, Davis CL, Povlishock JT. Quantitative analysis of the relationship between intra-axonal neurofilament compaction and impaired axonal transport following diffuse traumatic brain injury. J Neurotrauma 2005; 22 : 1066–80.
Barzo P, Marmarou A, Fatouros P, Hayasaki K and Corwin F. Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg 1997; 87: 900–907
Beaumont A, Marmarou A, Hayasaki K, Barzo P, Fatouros P, Corwin F, Marmarou C, Dunbar J. The permissive nature of blood brain barrier (BBB) opening in edema formation following traumatic brain injury. Acta Neurochir Suppl 2000;76: 125–9.
Beaumont A, Marmarou A, Czigner A, Yamamoto M, Demetriadou K, Shirotani T, Marmarou C, Dunbar J. The impact-acceleration model of head injury: Injury severity predicts motor and cognitive performance after trauma. Neurol Res 1999; 21: 742–54
Beaumont A, Marmarou C, Marmarou A. The effects of human corticotrophin releasing factor on motor and cognitive deficits after impact acceleration injury. Neurol Res 2000; 22: 665–73.
Marmarou CR, Povlishock JT. Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury. Exp Neurol 2006; 197: 353–62.
Signoretti S, Marmarou A, Tavazzi B, Lazzarino G, Beaumont A, Vagnozzi R. N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J Neurotrauma 2001; 18: 977–991
Pascual JM, Solivera J, Prieto R, Barrios L, Lopez-Larrubia P, Cerdan S and Roda JM. Time Course of early metabolic changes following diffuse traumatic brain injury in rats as detected by 1H NMR Spectroscopy. J Neurotrauma 2007; 24: 944–959
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science + Business Media, LLC
About this protocol
Cite this protocol
Marmarou, C.R., Prieto, R., Taya, K., Young, H.F., Marmarou, A. (2009). Marmarou Weight Drop Injury Model. In: Chen, J., Xu, Z.C., Xu, XM., Zhang, J.H. (eds) Animal Models of Acute Neurological Injuries. Springer Protocols Handbooks. Humana Press. https://doi.org/10.1007/978-1-60327-185-1_34
Download citation
DOI: https://doi.org/10.1007/978-1-60327-185-1_34
Publisher Name: Humana Press
Print ISBN: 978-1-60327-184-4
Online ISBN: 978-1-60327-185-1
eBook Packages: Springer Protocols